drugset / Trial / NCT01092299

A Bioavailability Study Comparing Modified-release Capsules and Immediate Release Capsules in Fed and Fasting Conditions

NCT01092299

Phase 1 Completed 62 enrolled AstraZeneca
RandomizedCrossoverDouble-blindBasic science

Summary

Part 1: The purpose of this study is to determine the pharmacokinetic profile of 4 different Extended/modified-release formulations and one immediate release formulation of AZD1446. In addition the food effect on AZD1446 pharmacokinetics will be investigated. Part 2: To asses the safety and tolerability of the selected formulation(s) from part 1 in elderly healthy volunteers.

Timeline

Start
2010-02
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD1446 Small molecule 90 mg Oral

Indications

No indication recorded.